Prostate-Specific Membrane Antigen-Guided Surgery.
Where this comes from
- Record sourced from PubMed, PMID 31732677.
- Also identified by DOI 10.2967/jnumed.119.232330.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Since its introduction to the diagnostic pathway for prostate cancer management, prostate-specific membrane antigen (PSMA)-ligand PET has demonstrated great potential. PSMA-ligand imaging is increasingly influencing therapeutic decision making, although its impact on patient outcomes still needs to be defined. One relatively new application, enabled through chemical and engineering efforts, is PSMA-guided surgery. This review highlights the potential of PSMA-guided surgery and discusses its implications in lymph node dissection in primary and recurrent prostate cancer.
Medical subject headings
- Prostatic Neoplasms
- Proteasome Endopeptidase Complex